NCT00592254

Brief Summary

The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential adult subjects for appropriate ADHD clinical research studies

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2002

Completed
5.1 years until next milestone

First Submitted

Initial submission to the registry

December 28, 2007

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 14, 2008

Completed
15.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

January 18, 2022

Status Verified

January 1, 2022

Enrollment Period

21 years

First QC Date

December 28, 2007

Last Update Submit

January 14, 2022

Conditions

ADHD

Keywords

ADHDAdults

Outcome Measures

Primary Outcomes (1)

  • Screening Protocol

    This study is a prescreening for possible entry into other studies

    Sreening

Study Arms (1)

A

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adults with symptoms of ADHD

You may qualify if:

  • Males and females ages 18-55
  • Subjects must have a DSM-IV or DSM-V diagnosis of ADHD, as determined by a clinical evaluation based on DSM-IV or DSM-V criteria

You may not qualify if:

  • History of head trauma with loss of consciousness, organic brain disorders, seizures, or neurosurgical intervention.
  • Any significant medical condition, in the judgment of the investigator
  • Mental retardation
  • Pregnancy of lactation
  • Subjects with a known recent history (within the past 6 months) of illicit drug or alcohol dependence
  • Sensory difficulties such as deafness or blindness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Related Links

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Joseph Biederman, MD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD

Study Record Dates

First Submitted

December 28, 2007

First Posted

January 14, 2008

Study Start

December 1, 2002

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

January 18, 2022

Record last verified: 2022-01

Locations

US(1)